Compare Mutual Funds
Pros | 3Y returns in the top 25% of the category. Beats FD returns for both 3Y & 5Y duration. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. |
INDMoney rank | 7/8 | 6/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 13 Years 6 Months | 13 Years 6 Months | ||
Fund AUM | ₹1056 Cr | ₹7898 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 1.3% | 0.93% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 45 | 39 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 2 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 98.67% | 99.46% | ||
Debt % | - | - | ||
P/E | 35.7 | 34.36 | ||
P/B | 5.13 | 5.45 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 9.93% | 7.97% | ||
3-Month Return | 7.64% | 5.66% | ||
6-Month Return | 1.83% | 1.64% | ||
1-Year Return | 11.36% | 7.02% | ||
3-Year Return | 26.71% | 23.73% | ||
5-Year Return | 15.64% | 14.96% |
Sharpe | 1.12 | 1.01 | ||
Alpha | 1.36 | -0.24 | ||
Beta | 0.96 | 0.91 | ||
Standard Deviation | 16.57 | 15.78 | ||
Information Ratio | 0.23 | -0.55 |
Description | UTI Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Kamal Gada | Sailesh Raj Bhan, Amber Singhania, Kinjal Desai |

